Results 231 to 240 of about 163,677 (304)

HIV Testing and Care Among Publicly Insured Enrollees With Schizophrenia: Is There a Benefit to Dual Eligibility?

Psychiatric Research and Clinical Practice, EarlyView.
Background Patients with schizophrenia experience gaps in the human immunodeficiency virus (HIV) care continuum. We examined the impact of dual enrollment in Medicare upon HIV testing and retention among Medicaid‐enrolled patients with schizophrenia.
Karly Murphy, Marilyn D. Thomas, Paola Alonso‐Fraire, Alexander R. Bazazi, Priya Dahiya, Mark Olfson, Francine Cournos, Emily Arnold, James Dilley, Paul Wesson, Richard Hermida, James Walkup, Stephen Crystal, Christina Mangurian   +13 more
wiley   +1 more source

Creativity Under Pressure: A Case Study of Drug Cartel Innovation

The Journal of Creative Behavior, Volume 60, Issue 4, December 2026.
ABSTRACT This article examines drug cartels as creative, innovation‐driven organizations rather than solely violent criminal enterprises. Building on creativity research applied to terrorist groups, we use a qualitative case study approach—drawing from news reports, official documents, open‐source materials, and academic work—to analyze 10 cases of ...
Isaac J. Moelter, Ares Boira‐Lopez, Sam Hunter, Amanda Moeller   +3 more
wiley   +1 more source

Evaluating Reduced Use and Abstinence as Outcomes in Pharmacotherapy Trials for Stimulant Use Disorder: A Meta-Analysis of 12 Randomized Controlled Trials. [PDF]

JAMA Psychiatry
Amin-Esmaeili M, Farokhnia M, Mojtabai R, Leggio L, Johnson RM, Susukida R.   +5 more
europepmc   +1 more source

Therapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model

Annals of Neurology, Volume 100, Issue 5, Page 1023-1027, November 2026.
Narcolepsy type 1 is characterized by cataplexy, for which current treatments targeting monoaminergic, histaminergic, and GABAergic pathways may be ineffective or poorly tolerated. We report the case of a 34‐year‐old man with narcolepsy type 1, intolerant to standard therapies, who experienced marked and sustained cataplexy reduction with morning ...
Francois Ricordeau, Sebastien Arthaud, Leila Langbour, Silvia Melzi, Aurelie Richard‐Mornas, Hannah Doudoux, Benjamin Rolland, Laure Peter‐Derex, Christelle Peyron   +8 more
wiley   +1 more source

US drug overdose deaths involving stimulants without opioids continued to rise in 2024. [PDF]

Addict Behav Rep
Jin Y, Li Z, Wu Q, Marshall BDL, Crable EL, Zang X.   +5 more
europepmc   +1 more source

Real‐Time Neurochemical Sensing in Zebrafish: Electrochemical and Fluorescent Approaches

Analysis &Sensing, Volume 6, Issue 6, November 2026.
The use of zebrafish has emerged as a powerful approach for real‐time neurochemical measurements. This review highlights recent advances in electrochemical and fluorescent sensing strategies that enable dynamic measurements in live preparations of this complex vertebrate. These complementary approaches provide new insights into neurochemical signaling,
Piyanka Hettiarachchi, Jacob T. Theismann, Michael A. Johnson   +2 more
wiley   +1 more source